Table 3 Treatment and clinical outcome of patients with eosinophilic myocarditis with and without cardiac magnetic resonance (CMR) imaging at presentation
From: Cardiac magnetic resonance in histologically proven eosinophilic myocarditis
All n = 27 | CMR n = 15 | No CMR n = 12 | p-value | |
|---|---|---|---|---|
Anti-inflammatory drugs, n (%) | ||||
Corticosteroid | 24 (89) | 14 (93) | 10 (83) | 0.569 |
Azathioprine | 3 (11) | 2 (13) | 1 (8) | 1.000 |
Methotrexate | 1 (4) | 1 (7) | 0 | 1.000 |
Cyclosporine | 2 (7) | 0 | 2 (17) | 0.188 |
Need for circulatory support | 13 (48) | 7 (47) | 6 (50) | 0.863 |
Inotropes, n (%) | 13 (48) | 7 (47) | 6 (50) | 0.863 |
Mechanical (ECMO), n (%) | 5 (19) | 3 (20) | 2 (17) | 1.000 |
Device therapy, n (%) | ||||
Temporary pacing | 3 (11) | 3 (20) | 0 | 0.231 |
Permanent pacemaker (no CRT-D) | 2 (7) | 1 (7) | 1 (8) | 1.000 |
CRT-D | 3 (11) | 2 (13) | 1 (8) | 1.000 |
Outcome | ||||
Follow-up time, ya | 3.8 (0.7–8.5) | 3.6 (1.1–7.0) | 4.7 (0.3–11.0) | 0.755 |
Cardiac death | 5 (19) | 1 (7) | 4 (33) | 0.139 |
VF or sustained VT | 2 (8) | 2 (14) | 0 | 1.000 |
Transplantation | 1 (4) | 0 | 1 (8) | 0.444 |